(1)
Jalali, F.; Moslemi, D.; Farjam, A. First Study of the Safety and Tolerability of Allvec-1, a Gene Therapy Vector, in Patients With Advanced Stage IV Malignant Solid Tumors. Reports-of-Radiotherapy-and-Onco 2015, 2, 1-6.